A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLL

Clinical trial NCT00435084 · COMPLETED

Trial details

NCT number: NCT00435084
Sponsor: Valerio Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Chronic Lymphocytic Leukemia

Start date: 2007-02-01
Primary completion: 2008-02-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.